Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Ikena Oncology Inc

IKNA
1,50
-0,01 (-0,66%)
Pre Mercato
Ultimo aggiornamento: 14:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/1/202512:30EDGAR2Form 425 - Prospectuses and communications, business..
23/12/202414:40EDGAR2Form 425 - Prospectuses and communications, business..
23/12/202414:37EDGAR2Form 8-K - Current report
23/12/202414:30GLOBEIkena Oncology and Inmagene Biopharmaceuticals Announce..
14/11/202423:05EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202414:30GLOBEIkena Oncology Reports Third Quarter 2024 Financial Results
07/11/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:15GLOBEIkena Oncology Reports Second Quarter 2024 Financial Results
08/8/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/7/202422:06EDGAR2Form 8-K - Current report
10/6/202422:05EDGAR2Form 8-K - Current report
28/5/202422:42GLOBEUPDATE – Ikena Oncology Announces Strategic Update
28/5/202422:24EDGAR2Form 8-K - Current report
28/5/202422:15GLOBEIkena Oncology Announces Strategic Update
13/5/202422:45GLOBEIkena Oncology Reports First Quarter 2024 Financial Results..
13/5/202422:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/4/202414:00GLOBEIkena Oncology to Present at the Stifel 2024 Virtual..
12/3/202413:00GLOBEIkena Oncology Reports Fourth Quarter and Full Year 2023..
05/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/2/202414:00GLOBEIkena Oncology to Participate in TD Cowen 44th Annual Health..
21/2/202422:29EDGAR2Form 8-K - Current report
21/2/202422:15GLOBEIkena Oncology Appoints Caroline Germa, M.D. as Chief..
02/2/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:26EDGAR2Form 8-K - Current report
18/1/202422:05GLOBEIkena Oncology Outlines Key Priorities and Provides..
Apertura: Min: Max:
Chiusura: 1,51

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network